Mosaic is absorbing a sulfur shock that has made phosphate production uneconomic across much of the footprint, and management chose to idle plants rather than manufacture losses into inventory. The Hormuz closure and a Kazakhstan blockade have broken sulfur logistics, while potash continues to throw off cash at Esterhazy and Belle Plaine. The investment debate is whether this is a finite raw-material interruption that leaves the franchise intact, or a longer stretch of thin cash conversion that forces more asset sales and stretches the balance sheet.
Adjusted earnings barely stayed positive after stripping notable items, even as the headline swung to a large loss on the Ma'aden mark, project write-offs, and currency. Phosphate sold fewer tonnes at a negative unit margin, Brazil idled commodity fertilizer, and Faustina sat completely down after July. Potash held operating profit nearly flat despite a planned Esterhazy turnaround and the April Carlsbad sale. That split is the whole story: one nutrient is a cash engine, the other is a stranded cost until sulfur normalizes.
The next several quarters resolve three variables. First, whether Gulf Coast sulfur contracts stay below spot enough to keep a stripping margin worth running. Second, whether potash volumes recover toward the nine-million-tonne production plan as Hydrofloat ramps. Third, whether Brazil working-capital release and the cut capital budget actually swing free cash flow positive in the second half. If sulfur stays scarce into next year, the equity is a waiting game priced at a deep discount to book. If logistics reopen, idle plants restart into a tight phosphate market.